Podcast TCTMD Talking Points The STAR-T/D Trial Michael Mack and C. Michael Gibson discuss a novel method for extracting antithrombotics from the blood during CABG.
Podcast TCTMD Talking Points The LOOP Study for AF Screening C. Michael Gibson and Jesper Hastrup Svendsen discuss the use of implantable loop recorders to prevent stroke in AF.
Podcast TCTMD Talking Points The ENVISAGE-TAVI AF Trial C. Michael Gibson and George Dangas discuss edoxaban vs vitamin K antagonists after TAVI in patients with atrial fibrillation.
Podcast TCTMD Talking Points The FIGARO-DKD Trial C. Michael Gibson and Bertam Pitt discuss the role of finerenone in patients with chronic kidney disease and type 2 diabetes.
Podcast TCTMD Talking Points AMULET-IDE: One-Year Outcomes C. Michael Gibson and Dhanunjaya Lakkireddy discuss device success and thrombus risk in Amulet versus Watchman for LAA closure.
Podcast TCTMD Talking Points Shock Classification Gets an Update C. Michael Gibson and Timothy Henry discuss key updates to the SCAI SHOCK classifications.
Podcast TCTMD Talking Points MICHELLE: Rivaroxaban in COVID-19 C. Michael Gibson and Renato Lopes discuss extended DOAC prophylaxis in medically ill, hospitalized patients with COVID-19.
Podcast TCTMD Talking Points The RIPCORD 2 Trial C. Michael Gibson and Nicholas Curzen discuss whether routine pressure-wire assessment influences the use of coronary angiography for diagnosing chest pain.
Podcast TCTMD Talking Points PARTNER 3: Two-Year Economic Outcomes C. Michael Gibson and David Cohen discuss cost implications of this TAVI versus SAVR randomized trial.
Podcast TCTMD Talking Points The IAMI Trial C. Michael Gibson and Ole Fröbert discuss the potential for influenza vaccination in post-MI patients.